JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.3B |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$1.64B |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.55B |
| 4 |
iShares MBS ETF
MBB
|
+$1.29B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$693M |
| 2 |
CVS Health
CVS
|
+$676M |
| 3 |
Johnson & Johnson
JNJ
|
+$669M |
| 4 |
Mondelez International
MDLZ
|
+$593M |
| 5 |
UnitedHealth
UNH
|
+$572M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.25% |
| 2 | Technology | 12.49% |
| 3 | Financials | 12.17% |
| 4 | Healthcare | 9.9% |
| 5 | Consumer Discretionary | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4701
Precigen
PGEN
$2.77B
| $97K | ﹤0.01% |
18,563
-844
| -4% | -$5.85K |
2013 Q3
22 quarters
|
|
4702
Invesco Aerospace & Defense ETF
PPA
$7.44B
| $97K | ﹤0.01% |
1,676
-79
| -5% | -$4.43K |
2016 Q4
9 quarters
|
|
|
CAI
4703
DELISTED
CAI International, Inc.
CAI
| $97K | ﹤0.01% |
4,200
-75,624
| -95% | -$1.81M |
2017 Q3
6 quarters
|
|
4704
PUT
Rithm Capital
RITM
$4.88B
| $96K | ﹤0.01% |
+5,700
| New | +$93.9K |
2019 Q1
0 quarters
|
|
|
CRCM
4705
DELISTED
CARE.COM, INC.
CRCM
| $96K | ﹤0.01% |
4,863
-109,915
| -96% | -$2.47M |
2017 Q3
6 quarters
|
|
4706
PUT
Under Armour
UAA
$2.02B
| $95K | ﹤0.01% |
+4,500
| New | +$94.3K |
2019 Q1
0 quarters
|
|
4707
Xeris Biopharma Holdings
XERS
$1.85B
| $95K | ﹤0.01% |
9,443
+7,734
| +453% | +$99.1K |
2018 Q3
2 quarters
|
|
|
BVH
4708
DELISTED
Bluegreen Vacations Holding Corporation
BVH
| $95K | ﹤0.01% |
3,203
-150
| -4% | -$4.59K |
2018 Q2
3 quarters
|
|
|
SRGA
4709
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $95K | ﹤0.01% |
523
-416
| -44% | -$60.2K |
2017 Q4
5 quarters
|
|
|
EPE
4710
DELISTED
EP Energy Corporation
EPE
| $95K | ﹤0.01% |
366,052
-2,964,449
| -89% | -$1.96M |
2014 Q1
20 quarters
|
|
4711
Equity Bancshares
EQBK
$979M
| $94K | ﹤0.01% |
3,262
-154
| -5% | -$5.02K |
2017 Q3
6 quarters
|
|
4712
Tejon Ranch
TRC
$437M
| $94K | ﹤0.01% |
5,376
+1
| +0% | +$18 |
2015 Q4
13 quarters
|
|
4713
Hackett Group
HCKT
$269M
| $93K | ﹤0.01% |
5,879
-276
| -4% | -$4.73K |
2015 Q4
13 quarters
|
|
|
EIDX
4714
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $93K | ﹤0.01% |
3,947
+2,093
| +113% | +$33.6K |
2018 Q3
2 quarters
|
|
|
USFR
4715
DELISTED
WisdomTree Bloomberg Floating Rate Treasury Fund
USFR
| $93K | ﹤0.01% |
+3,697
| New | +$93K |
2019 Q1
0 quarters
|
|
4716
ProShares UltraShort Bloomberg Crude Oil
SCO
$1.01B
| $92K | ﹤0.01% |
+68
| New | +$111K |
2019 Q1
0 quarters
|
|
4717
Direxion Daily 20+ Year Treasury Bear 3X ETF
TMV
$246M
| $92K | ﹤0.01% |
2,305
-188
| -8% | -$8.53K |
2018 Q3
2 quarters
|
|
|
USWS
4718
DELISTED
U.S. Well Services, Inc. Class A Common Stock
USWS
| $92K | ﹤0.01% |
+552
| New | +$91K |
2019 Q1
0 quarters
|
|
|
LN
4719
DELISTED
LINE Corporation
LN
| $92K | ﹤0.01% |
2,617
-3,921
| -60% | -$141K |
2017 Q2
7 quarters
|
|
|
NVTR
4720
DELISTED
Nuvectra Corporation Common Stock
NVTR
| $92K | ﹤0.01% |
8,375
+3,954
| +89% | +$53.4K |
2016 Q1
12 quarters
|
|
4721
Cytokinetics
CYTK
$8.72B
| $91K | ﹤0.01% |
11,217
-527
| -4% | -$3.88K |
2017 Q4
5 quarters
|
|
4722
iShares MSCI Intl Quality Factor ETF
IQLT
$13.7B
| $91K | ﹤0.01% |
3,111
+1,361
| +78% | +$38.1K |
2018 Q4
1 quarter
|
|
4723
State Street SPDR Dow Jones Global Real Estate ETF
RWO
$1.16B
| $91K | ﹤0.01% |
1,814
-2,638
| -59% | -$127K |
2017 Q4
5 quarters
|
|
4724
CALL
Simon Property Group
SPG
$65.2B
| $91K | ﹤0.01% |
+500
| New | +$88.9K |
2019 Q1
0 quarters
|
|
4725
iShares Global Infrastructure ETF
IGF
$10.2B
| $90K | ﹤0.01% |
2,000
| – | – |
2013 Q2
23 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2019 Portfolio in Review
As of Q1 2019, JP Morgan Chase held 6,314 positions worth $490B, up 13% from $432B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q1 2019 filing shows 537 new, 2,080 increased, 2,670 reduced and 537 closed positions. Its largest new stake was Lyft: 2,510,596 shares worth $197M. The largest sale was Apple, an estimated $693M.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 26% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q1 2019 buy was Lyft: 2,510,596 shares worth $197M.
- JP Morgan Chase added most to Vanguard Total International Bond ETF in Q1 2019, an estimated $2.3B increase.
- JP Morgan Chase's biggest Q1 2019 reduction was Apple, cutting an estimated $693M.
- JP Morgan Chase fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $164M.
- JP Morgan Chase's ten largest holdings make up 16% of its $490B portfolio in Q1 2019.
- JP Morgan Chase opened 537 new positions and closed 537 in Q1 2019.
- JP Morgan Chase's portfolio value rose 13% quarter-over-quarter to $490B.
Based on JP Morgan Chase's 13F filing for Q1 2019, filed 7 May 2019.